Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000562

Drug Information
NameEdrophonium
SynonymsAR-1H8213; Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium; AC1L1FEK; N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium; KBio2_000922; NINDS_000809; CID3202; KBio1_000809; SPBio_001945; Spectrum_000442; BSPBio_002386; KBioGR_001032; NCGC00015409-01; C06976; Prestwick2_000083; N-ethyl-3-hydroxy-N,N-dimethylanilinium; ENLON-PLUS; Lopac-E-3256; Edrophonum; Enlon Plus; UNII-70FP3JLY7N; MolPort-005-942-309; Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-; Spectrum5_001531; BSPBio_000006; KBio2_006058; AB00053796; Edrophone Chloride; Prestwick1_000083; CHEBI:251408; EDR; DivK1c_000809; C10H16NO.Cl; IDI1_000809; AC1Q7AIY; NCGC00015409-02; CHEMBL1104; NCGC00023975-03; Lopac0_000511; KBioSS_000922; edrophonium; 312-48-1; ethyl-(3-hydroxyphenyl)-dimethylazanium; Prestwick3_000083; DB01010; NCGC00015409-07; 116-38-1 (cloride); Tensilon; Edroponium; LS-174330; KBio2_003490; Spectrum4_000736; BPBio1_000008; Prestwick0_000083; (3-hydroxyphenyl)dimethylethylammonium; EDROPHONIUM ION; Reversol; ZINC00001341; Spectrum2_001110; 3-hydroxy-N,N-dimethyl-N-ethylanilinium; SPBio_001220; NCGC00015409-03; CAS-116-38-1
Trade NameTensilon; Enlon; Reversol
IndicationDiagnosis of myasthenia gravis
[ICD9: 358.0   ICD10: G70.0]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1
InChIKeyVWLHWLSRQJQWRG-UHFFFAOYSA-O
Canonical SMILESCC[N+](C)(C)C1=CC(=CC=C1)O    
Therapeutic ClassAntidotes
CAS NumberCAS 116-38-1
FormulaC10H16NO
PubChem Compound IDCID 3202.
PubChem Substance IDSID 9190.
TargetAcetylcholinesteraseInhibitor[2][3][4]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040131 To Reference
Ref 2Screening of acetylcholinesterase inhibitors by CE after enzymatic reaction at capillary inlet. J Sep Sci. 2009 May;32(10):1748-56. To Reference
Ref 3Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries. Curr Med Res Opin. 2009 Apr;25(4):943-50. To Reference
Ref 4Stabilization of Torpedo californica acetylcholinesterase by reversible inhibitors. Biochemistry. 2009 Jan 27;48(3):563-74. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543